Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Recursion Pharmaceuticals, Inc. - Class A Common Stock
(NQ:
RXRX
)
4.832
+0.122 (+2.59%)
Streaming Delayed Price
Updated: 1:47 PM EST, Dec 8, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
July 12, 2023
Via
Benzinga
Recursion Announces Collaboration and $50 Million Investment from NVIDIA to Accelerate Groundbreaking Foundation Models in AI-Enabled Drug Discovery
July 12, 2023
Companies to collaborate on software for biotech and pharmaceutical companies to create improved patient treatments faster
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Nanobiotix, NanoString Technologies And Other Big Stocks Moving Higher In Monday's Pre-Market Session
↗
July 10, 2023
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Expert Ratings for Recursion Pharmaceuticals
↗
May 09, 2023
Via
Benzinga
Recursion Pharmaceuticals's Return On Capital Employed Overview
↗
March 03, 2023
Via
Benzinga
Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom
↗
July 08, 2023
AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider.
Via
InvestorPlace
Cash In on the Longevity Boom: 3 Biotech Stocks to Buy Now
↗
June 29, 2023
With longevity back in the news, many investors are wondering which biotech stocks to buy to best cash in on the growing trend.
Via
InvestorPlace
Recursion Celebrates Opening of Its Canadian Headquarters in Toronto with Government Officials and the Biotech Ecosystem
June 26, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Recursion’s Phase 2 Trial for the Treatment of Cerebral Cavernous Malformation has Fully Enrolled
June 13, 2023
Recursion's small molecule is the first therapeutic candidate to be advanced to an industry-sponsored Phase 2 clinical trial for cerebral cavernous malformation (CCM). CCM is a devastating...
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Recursion to Participate in Upcoming Investor Conferences
June 01, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Recursion Pharmaceuticals Is Going Big on AI. Here's Why It Could Be Worth Buying
↗
May 29, 2023
It's competing in a soon-to-be hotly contested space.
Via
The Motley Fool
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
↗
May 23, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 22, 2023
Via
Benzinga
Why ZIM Integrated Shipping Services Shares Are Trading Lower By 14%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
May 22, 2023
Gainers Greenhill & Co., Inc. (NYSE: GHL) shares jumped 116.4% to $14.67 after Mizuho announced it would acquire the company for $15 per share.
Via
Benzinga
Recursion Appoints David Mauro, M.D., Ph.D., as Chief Medical Officer
May 16, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Recursion Provides Business Updates and Reports First Quarter 2023 Financial Results
May 08, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Recursion Enters into Agreements to Acquire Cyclica and Valence to Bolster Chemistry and Generative AI Capabilities
May 08, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
Recursion to Participate in Upcoming Investor Conferences
May 02, 2023
From
Recursion Pharmaceuticals
Via
GlobeNewswire
12 Health Care Stocks Moving In Friday's After-Market Session
↗
April 07, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
↗
March 16, 2023
Via
Benzinga
Cathie Wood Makes Biggest Coinbase Purchase Of Year After Earnings Beat
↗
February 23, 2023
Cathie Wood and her ARK Invest firm bought $13 million in COIN stock as they bulk up holdings following Coinbase earnings.
Via
Investor's Business Daily
$2M Bet On PayPal? Check Out These 4 Stocks Insiders Are Buying
↗
February 21, 2023
Although US stocks closed mixed on Friday, there were a few notable insider trades.
Via
Benzinga
$6M Bet On RxSight? Check Out These 3 Stocks Insiders Are Buying
↗
February 14, 2023
Although US stocks closed higher on Monday, there were a few notable insider trades.
Via
Benzinga
Delta Apparel, Farfetch, American Software And Some Other Big Stocks Moving Lower On Friday
↗
November 18, 2022
U.S. stocks traded mixed, with the Dow Jones gaining more than 80 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Recursion Pharma Stock Earns Relative Strength Rating Upgrade; Hits Key Benchmark
↗
September 26, 2022
Recursion Pharma stock cleared a key performance benchmark Monday, with its Relative Strength Rating upgraded to 89 from 76 the day before.
Via
Investor's Business Daily
FedEx, NCR, International Paper And Other Big Losers From Friday
↗
September 19, 2022
U.S. stocks closed lower with the Nasdaq Composite dropping over 100 points on Friday. Here is the list of some big stocks recording losses in the previous session.
Via
Benzinga
Why Aditxt Shares Dipped Over 58%; Here Are 82 Biggest Movers From Friday
↗
September 19, 2022
Gainers Panbela Therapeutics, Inc. (NASDAQ: PBLA) shares jumped 53% to close at $0.58 on Friday.
Via
Benzinga
Why NCR Is Trading Lower By Around 23%, Here Are 42 Stocks Moving In Friday's Mid-Day Session
↗
September 16, 2022
Gainers Kensington Capital Acquisition Corp. IV (NYSE: AMPX) jumped 35.4% to $13.54 after gaining 11% on Thursday.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 16, 2022
↗
September 16, 2022
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
↗
August 12, 2022
Via
Benzinga
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
